NG
MEDP icon

Novem Group’s Medpace MEDP Stock Holding History

Novem Group’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.11M Buy
2,105
+139
+7% +$64.2K 0.11% 163
2026
Q1 		$944K Buy
1,966
+129
+7% +$66.1K 0.11% 182
2025
Q4 		$1.03M Sell
1,837
-1,101
-37% -$625K 0.12% 164
2025
Q3 		$1.51M Sell
2,938
-42
-1% -$18.3K 0.18% 103
2025
Q2 		$935K Buy
2,980
+56
+2% +$16.8K 0.12% 162
2025
Q1 		$891K Buy
2,924
+763
+35% +$257K 0.13% 161
2024
Q4 		$718K Buy
+2,161
New +$733K 0.1% 180

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Novem Group's MEDP Position: Q2 2026 in Review

Novem Group increased its Medpace (MEDP) stake by 7.1% in Q2 2026, buying an estimated $64.2K and bringing the position to 2,105 shares worth $1.11M. The position accounts for 0.11% of the portfolio, ranked #163.

Novem Group first reported a position in MEDP in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.51M in Q3 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Novem Group held 2,105 shares of Medpace worth $1.11M as of Q2 2026.
  • Novem Group bought 139 Medpace shares in Q2 2026, an estimated $64.2K.
  • Medpace made up 0.11% of Novem Group's portfolio in Q2 2026, its #163 holding.
  • Novem Group first reported a position in Medpace in Q4 2024 and has held it in 7 quarters since.
  • Novem Group's Medpace position peaked at $1.51M in Q3 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Novem Group's 13F filing for Q2 2026, filed 21 Jul 2026.